Matches in SemOpenAlex for { <https://semopenalex.org/work/W3140938089> ?p ?o ?g. }
- W3140938089 endingPage "790" @default.
- W3140938089 startingPage "782" @default.
- W3140938089 abstract "Bruton's tyrosine kinase (BTK) is a cytoplasmic tyrosine kinase that plays a critical role in the activation of B cells, macrophages, and osteoclasts. Given the key role of these cell types in the pathology of autoimmune disorders, BTK inhibitors have the potential to improve treatment outcomes in multiple diseases. Herein, we report the discovery and characterization of a novel potent and selective covalent 4-oxo-4,5-dihydro-3H-1-thia-3,5,8-triazaacenaphthylene-2-carboxamide BTK inhibitor chemotype. Compound 27 irreversibly inhibits BTK by targeting a noncatalytic cysteine residue (Cys481) for covalent bond formation. Compound 27 is characterized by selectivity for BTK, potent in vivo BTK occupancy that is sustained after it is cleared from systemic circulation, and dose-dependent efficacy at reducing joint inflammation in a rat collagen-induced arthritis model." @default.
- W3140938089 created "2021-04-13" @default.
- W3140938089 creator A5003569889 @default.
- W3140938089 creator A5005379705 @default.
- W3140938089 creator A5006328928 @default.
- W3140938089 creator A5010809815 @default.
- W3140938089 creator A5012465290 @default.
- W3140938089 creator A5013313835 @default.
- W3140938089 creator A5022752986 @default.
- W3140938089 creator A5024279217 @default.
- W3140938089 creator A5026019470 @default.
- W3140938089 creator A5026952377 @default.
- W3140938089 creator A5039448694 @default.
- W3140938089 creator A5042767442 @default.
- W3140938089 creator A5047390362 @default.
- W3140938089 creator A5050929140 @default.
- W3140938089 creator A5062210953 @default.
- W3140938089 creator A5062881671 @default.
- W3140938089 creator A5062929535 @default.
- W3140938089 creator A5077736641 @default.
- W3140938089 creator A5079462694 @default.
- W3140938089 creator A5079741618 @default.
- W3140938089 creator A5081779719 @default.
- W3140938089 creator A5091761903 @default.
- W3140938089 date "2021-04-05" @default.
- W3140938089 modified "2023-10-16" @default.
- W3140938089 title "Discovery of a Potent and Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase with Oral Anti-Inflammatory Activity" @default.
- W3140938089 cites W1563650227 @default.
- W3140938089 cites W1768316631 @default.
- W3140938089 cites W2019216438 @default.
- W3140938089 cites W2057079741 @default.
- W3140938089 cites W2062482627 @default.
- W3140938089 cites W2122839730 @default.
- W3140938089 cites W2163054872 @default.
- W3140938089 cites W2166422945 @default.
- W3140938089 cites W2167854315 @default.
- W3140938089 cites W2316021978 @default.
- W3140938089 cites W2513274461 @default.
- W3140938089 cites W2783904016 @default.
- W3140938089 cites W2788356134 @default.
- W3140938089 cites W2792062848 @default.
- W3140938089 cites W2917868259 @default.
- W3140938089 cites W2924154682 @default.
- W3140938089 cites W2924170743 @default.
- W3140938089 cites W2943412515 @default.
- W3140938089 cites W2944582362 @default.
- W3140938089 cites W2952113952 @default.
- W3140938089 cites W2972482801 @default.
- W3140938089 cites W2998736613 @default.
- W3140938089 cites W3006348927 @default.
- W3140938089 cites W3006726493 @default.
- W3140938089 cites W3013682926 @default.
- W3140938089 cites W3016222021 @default.
- W3140938089 cites W4242768823 @default.
- W3140938089 doi "https://doi.org/10.1021/acsmedchemlett.1c00044" @default.
- W3140938089 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8155241" @default.
- W3140938089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34055226" @default.
- W3140938089 hasPublicationYear "2021" @default.
- W3140938089 type Work @default.
- W3140938089 sameAs 3140938089 @default.
- W3140938089 citedByCount "7" @default.
- W3140938089 countsByYear W31409380892021 @default.
- W3140938089 countsByYear W31409380892022 @default.
- W3140938089 countsByYear W31409380892023 @default.
- W3140938089 crossrefType "journal-article" @default.
- W3140938089 hasAuthorship W3140938089A5003569889 @default.
- W3140938089 hasAuthorship W3140938089A5005379705 @default.
- W3140938089 hasAuthorship W3140938089A5006328928 @default.
- W3140938089 hasAuthorship W3140938089A5010809815 @default.
- W3140938089 hasAuthorship W3140938089A5012465290 @default.
- W3140938089 hasAuthorship W3140938089A5013313835 @default.
- W3140938089 hasAuthorship W3140938089A5022752986 @default.
- W3140938089 hasAuthorship W3140938089A5024279217 @default.
- W3140938089 hasAuthorship W3140938089A5026019470 @default.
- W3140938089 hasAuthorship W3140938089A5026952377 @default.
- W3140938089 hasAuthorship W3140938089A5039448694 @default.
- W3140938089 hasAuthorship W3140938089A5042767442 @default.
- W3140938089 hasAuthorship W3140938089A5047390362 @default.
- W3140938089 hasAuthorship W3140938089A5050929140 @default.
- W3140938089 hasAuthorship W3140938089A5062210953 @default.
- W3140938089 hasAuthorship W3140938089A5062881671 @default.
- W3140938089 hasAuthorship W3140938089A5062929535 @default.
- W3140938089 hasAuthorship W3140938089A5077736641 @default.
- W3140938089 hasAuthorship W3140938089A5079462694 @default.
- W3140938089 hasAuthorship W3140938089A5079741618 @default.
- W3140938089 hasAuthorship W3140938089A5081779719 @default.
- W3140938089 hasAuthorship W3140938089A5091761903 @default.
- W3140938089 hasConcept C150903083 @default.
- W3140938089 hasConcept C178790620 @default.
- W3140938089 hasConcept C180577832 @default.
- W3140938089 hasConcept C185592680 @default.
- W3140938089 hasConcept C203014093 @default.
- W3140938089 hasConcept C207001950 @default.
- W3140938089 hasConcept C2776165026 @default.
- W3140938089 hasConcept C2777938653 @default.
- W3140938089 hasConcept C2778461978 @default.
- W3140938089 hasConcept C2779878957 @default.
- W3140938089 hasConcept C42362537 @default.